🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
This study is being done to assess the safety and tolerance of different do...
Status
Completed
Location
Service Des Maladies Du Sang
Start Date
2004-03
Trial ID
NCT00596804
Treatments Being Tested
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
University of Arizona Cancer Center - North Campus /ID# 16721
Start Date
2009-07-21
Trial ID
NCT00788684
The primary objective of the study is to evaluate the safety and tolerabili...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2018-09-04
Trial ID
NCT04152148
Treatments Being Tested
The main purpose of this study is to explore the sequential therapeutic eff...
Status
Unknown
Location
Southwest Hospital of Third Millitary Medical University
Start Date
2016-03
Trial ID
NCT02737085
Treatments Being Tested
This Phase I Clinical Study assessed the Safety, Tolerability, Pharmacokine...
Status
Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2023-03-02
Trial ID
NCT05668403
The purpose of this study is to determine whether rituximab is effective in...
Status
Completed
Location
Cochin Hospital
Start Date
2013-04-09
Trial ID
NCT01748084
Treatments Being Tested
The purpose is to identify a dose of SB-485232 which is safe, tolerable and...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-31
Trial ID
NCT00500058
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
This is an open label clinical study: Phase Ia is a dose escalation phase, ...
Status
Recruiting
Location
The First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-07-01
Trial ID
NCT07073833
Treatments Being Tested